Resveratrol treatment after status epilepticus restrains neurodegeneration and abnormal neurogenesis with suppression of oxidative stress and inflammation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Mishra, Vikas ^a,b,c   Shuai, Bing ^a,b,c   Kodali, Maheedhar ^a,b,c   Shetty, Geetha A ^a,b,c   Hattiangady, Bharathi ^a,b,c   Rao, Xiaolan ^a,b,c   Shetty, Ashok K ^a,b,c  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NEUROPEPTIDE Y; PARVALBUMIN; REELIN PROTEIN; RESVERATROL; SCLEROPROTEIN; SERINE PROTEINASE; SOMATOSTATIN; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL; ANIMAL BEHAVIOR; CELL DEATH; COGNITION; COMPLICATION; DRUG EFFECTS; FISCHER 344 RAT; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; INFLAMMATION; INTERNEURON; LONGEVITY; MALE; METABOLISM; MICROGLIA; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; SEIZURES; STATUS EPILEPTICUS;

ANIMALS; BEHAVIOR, ANIMAL; CELL ADHESION MOLECULES, NEURONAL; CELL DEATH; COGNITION; EXTRACELLULAR MATRIX PROTEINS; GABAERGIC NEURONS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFLAMMATION; INTERNEURONS; LONGEVITY; MALE; MICROGLIA; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEUROGENESIS; NEUROPEPTIDE Y; OXIDATIVE STRESS; PARVALBUMINS; RATS, INBRED F344; SEIZURES; SERINE ENDOPEPTIDASES; SOMATOSTATIN; STATUS EPILEPTICUS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949604107     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17807     Document Type: Article

References (73)

1. Hattiangady, B., Rao, M. S. & Shetty, A. K. Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol. Dis. 17, 473-490 (2004).
2. Hattiangady, B. & Shetty, A. K. Decreased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy. Hippocampus 20, 97-112 (2010).
3. Ben-Ari, Y. In Jasper's Basic Mechanisms of the Epilepsies (eds Noebels, J. L., Avoli, M., Rogawski, M. A., Olsen, R. W. & Delgado-Escueta, A. V.) (Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen, Bethesda (MD), 2012).
4. Kleen, J. K., Scott, R. C., Lenck-Santini, P. P. & Holmes, G. L. In Jasper's Basic Mechanisms of the Epilepsies (eds Noebels, J. L., Avoli, M., Rogawski, M. A., Olsen, R. W. & Delgado-Escueta, A. V.) (Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen, Bethesda (MD), 2012).
5. Loscher, W. In Jasper's Basic Mechanisms of the Epilepsies (eds Noebels, J. L., Avoli, M., Rogawski, M. A., Olsen, R. W. & Delgado-Escueta, A. V.) (Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen, Bethesda (MD), 2012).
6. Sankar, R. & Mazarati, A. in Jasper's Basic Mechanisms of the Epilepsies (eds Noebels, J. L., Avoli, M., Rogawski, M. A., Olsen, R. W. & Delgado-Escueta, A. V.) (Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen, Bethesda (MD), 2012).
7. Fellin, T. & Haydon, P. G. Do astrocytes contribute to excitation underlying seizures? Trends Mol. Med. 11, 530-533 (2005).
8. Vezzani, A., French, J., Bartfai, T. & Baram, T. Z. The role of inflammation in epilepsy. Nat. Rev. Neurol. 7, 31-40 (2011).
9. Parent, J. M. et al. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci. 17, 3727-3738 (1997).
10. Shetty, A. K. & Hattiangady, B. Concise review: prospects of stem cell therapy for temporal lobe epilepsy. Stem Cells 25, 2396-2407 (2007).
11. Scharfman, H. E. & Pierce, J. P. New insights into the role of hilar ectopic granule cells in the dentate gyrus based on quantitative anatomic analysis and three-dimensional reconstruction. Epilepsia 53 Suppl 1, 109-115 (2012).
12. Hattiangady, B., Kuruba, R. & Shetty, A. K. Acute Seizures in Old Age Leads to a Greater Loss of CA1 Pyramidal Neurons, an Increased Propensity for Developing Chronic TLE and a Severe Cognitive Dysfunction. Aging Dis. 2, 1-17 (2011).
13. Coras, R. et al. Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans. Brain 133, 3359-3372 (2010).
14. Waldau, B., Hattiangady, B., Kuruba, R. & Shetty, A. K. Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells 28, 1153-1164 (2010).
15. Temkin, N. R. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-Analysis of controlled trials. Epilepsia 42, 515-524 (2001).
16. Temkin, N. R. Causes and prevention of symptomatic epilepsy: a clinical survey. Löscher W., Schmidt D. editors. New Horizons in the development of antiepileptic drugs II: The search for new targets. Epilepsy Res 60, 80-83 (2004).
17. Dichter, M. A. Posttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure. Epilepsia 50 Suppl 2, 41-45 (2009).
18. Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689 (2004).
19. Baur, J. A. et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (2006).
20. Shetty, A. K. Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacol. Ther. 131, 269-286 (2011).
21. Chung, J. H., Manganiello, V. & Dyck, J. R. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 22, 546-554 (2012).
22. Wu, Z. et al. Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem. Res. 34, 1393-1400 (2009).
23. Zini, R., Morin, C., Bertelli, A., Bertelli, A. A. & Tillement, J. P. Effects of resveratrol on the rat brain respiratory chain. Drugs Exp. Clin. Res. 25, 87-97 (1999).
24. Sun, A. Y., Chen, Y. M., James-Kracke, M., Wixom, P. & Cheng, Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem. Res. 22, 1187-1192 (1997).
25. Manna, S. K., Mukhopadhyay, A. & Aggarwal, B. B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164, 6509-6519 (2000).
26. Wang, Q. et al. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res. 29, 2105-2112 (2004).
27. Sinha, K., Chaudhary, G. & Gupta, Y. K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 71, 655-665 (2002).
28. Wang, Q. et al. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958, 439-447 (2002).
29. Liu, C. et al. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res. 1374, 100-109 (2011).
30. Singleton, R. H., Yan, H. Q., Fellows-Mayle, W. & Dixon, C. E. Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J. Neurotrauma 27, 1091-1099 (2010).
31. Gupta, Y. K., Chaudhary, G. & Srivastava, A. K. Protective effect of resveratrol against pentylenetetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology 65, 170-174 (2002).
32. Gupta, Y. K., Briyal, S. & Chaudhary, G. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav. 71, 245-249 (2002).
33. Wang, H. M. et al. Neuroprotective effects of forsythiaside on learning and memory deficits in senescence-Accelerated mouse prone (SAMP8) mice. Pharmacol. Biochem. Behav. 105, 134-141 (2013).
34. Rao, M. S., Hattiangady, B., Reddy, D. S. & Shetty, A. K. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J. Neurosci. Res. 83, 1088-1105 (2006).
35. Rao, M. S., Hattiangady, B., Rai, K. S. & Shetty, A. K. Strategies for promoting anti-seizure effects of hippocampal fetal cells grafted into the hippocampus of rats exhibiting chronic temporal lobe epilepsy. Neurobiol. Dis. 27, 117-132 (2007).
36. Hattiangady, B., Rao, M. S. & Shetty, A. K. Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy. Exp. Neurol. 212, 468-481 (2008).
37. Kuruba, R., Hattiangady, B. & Shetty, A. K. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav. 14 Suppl 1, 65-73 (2009).
38. Wasterlain, C. G., Naylor, D. E., Liu, H., Niquet, J. & Baldwin, R. Trafficking of NMDA receptors during status epilepticus: therapeutic implications. Epilepsia 54 Suppl 6, 78-80 (2013).
39. Furukawa, A. et al. Proteomic identification of hippocampal proteins vulnerable to oxidative stress in excitotoxin-induced acute neuronal injury. Neurobiol. Dis. 43, 706-714 (2011).
40. Waldbaum, S. & Patel, M. Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 88, 23-45 (2010).
41. Janigro, D., Iffland, P. H., 2nd, Marchi, N. & Granata, T. A role for inflammation in status epilepticus is revealed by a review of current therapeutic approaches. Epilepsia 54 Suppl 6, 30-32 (2013).
42. Chen, J. W. & Wasterlain, C. G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 5, 246-256 (2006).
43. Vezzani, A., Sperk, G. & Colmers, W. F. NEuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22, 25-30 (1999).
44. Schwaller, B. et al. Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol. Cell. Neurosci. 25, 650-663 (2004).
45. Murray, A. J. et al. Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory. Nat. Neurosci. 14, 297-299 (2011).
46. Houser, C. R. Do structural changes in GABA neurons give rise to the epileptic state? Adv. Exp. Med. Biol. 813, 151-160 (2014).
47. Kim, H. J., Kim, I. K., Song, W., Lee, J. & Park, S. The synergic effect of regular exercise and resveratrol on kainate-induced oxidative stress and seizure activity in mice. Neurochem. Res. 38, 117-122 (2013).
48. Detampel, P., Beck, M., Krahenbuhl, S. & Huwyler, J. Drug interaction potential of resveratrol. Drug Metab Rev. 44, 253-265 (2012)
49. Menon, B., Ramalingam, K. & Kumar, R. V. Oxidative stress in patients with epilepsy is independent of antiepileptic drugs. Seizure 21, 780-784 (2012).
50. Cucciolla, V. et al. Resveratrol: from basic science to the clinic. Cell. Cycle 6, 2495-2510 (2007).
51. Lin, C. J., Chen, T. H., Yang, L. Y. & Shih, C. M. Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell. Death Dis. 5, e1147 (2014).
52. Friedman, L. K., Goldstein, B., Rafiuddin, A., Roblejo, P. & Friedman, S. Lack of resveratrol neuroprotection in developing rats treated with kainic acid. Neuroscience 230, 39-49 (2013).
53. Mattson, M. P. & Meffert, M. K. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13, 852-860 (2006).
54. Hayden, M. S. & Ghosh, S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26, 203-234 (2012).
55. Amor, S. et al. Inflammation in neurodegenerative diseases-An update. Immunology 142, 151-166 (2014).
56. Vezzani, A., Aronica, E., Mazarati, A. & Pittman, Q. J. Epilepsy and brain inflammation. Exp. Neurol. 244, 11-21 (2013).
57. Prinz, M. & Priller, J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15, 300-312 (2014).
58. Parent, J. M. & Kron, M. M. In Jasper's Basic Mechanisms of the Epilepsies (eds Noebels, J. L., Avoli, M., Rogawski, M. A., Olsen, R. W. & Delgado-Escueta, A. V.) (Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen, Bethesda (MD), 2012).
59. Cho, K. O. et al. Aberrant hippocampal neurogenesis contributes to epilepsy and associated cognitive decline. Nat. Commun. 6, 6606 (2015).
60. Scharfman, H. E., Goodman, J. H. & Sollas, A. L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci. 20, 6144-6158 (2000).
61. Scharfman, H. E. Does the Development of a GABAergic Phenotype by Hippocampal Dentate Gyrus Granule Cells Contribute to Epileptogenesis. Epilepsy Curr. 2, 63 (2002).
62. Scharfman, H. E., Sollas, A. L. & Goodman, J. H. Spontaneous recurrent seizures after pilocarpine-induced status epilepticus activate calbindin-immunoreactive hilar cells of the rat dentate gyrus. Neuroscience 111, 71-81 (2002).
63. Scharfman, H. E., Sollas, A. L., Berger, R. E. & Goodman, J. H. Electrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sprouting. J. Neurophysiol. 90, 2536-2547 (2003).
64. McCloskey, D. P., Hintz, T. M., Pierce, J. P. & Scharfman, H. E. Stereological methods reveal the robust size and stability of ectopic hilar granule cells after pilocarpine-induced status epilepticus in the adult rat. Eur. J. Neurosci. 24, 2203-2210 (2006).
65. Hester, M. S. & Danzer, S. C. Hippocampal granule cell pathology in epilepsy-A possible structural basis for comorbidities of epilepsy? Epilepsy Behav. 38, 105-116 (2014).
66. Gong, C., Wang, T. W., Huang, H. S. & Parent, J. M. Reelin regulates neuronal progenitor migration in intact and epileptic hippocampus. J. Neurosci. 27, 1803-1811 (2007).
67. Kodali, M. et al. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci. Rep. 5, 8075 (2015).
68. Rao, M. S. & Shetty, A. K. Efficacy of doublecortin as a marker to analyze the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus. Eur. J. Neurosci. 19, 234-246 (2004).
69. Rao, M. S., Hattiangady, B., Abdel-Rahman, A., Stanley, D. P. & Shetty, A. K. Newly born cells in the ageing dentate gyrus display normal migration, survival and neuronal fate choice but endure retarded early maturation. Eur. J. Neurosci. 21, 464-476 (2005).
70. Rao, M. S., Hattiangady, B. & Shetty, A. K. The window and mechanisms of major age-related decline in the production of new neurons within the dentate gyrus of the hippocampus. Aging Cell. 5, 545-558 (2006).
71. Hattiangady, B., Rao, M. S., Shetty, G. A. & Shetty, A. K. Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and nEuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus. Exp. Neurol. 195, 353-371 (2005).
72. Kuruba, R., Hattiangady, B., Parihar, V. K., Shuai, B. & Shetty, A. K. Differential susceptibility of interneurons expressing nEuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. PLoS One 6, e24493 (2011).
73. Shetty, G. A., Hattiangady, B. & Shetty, A. K. Neural stem cell-And neurogenesis-related gene expression profiles in the young and aged dentate gyrus. Age (Dordr) 35, 2165-2176 (2013).